CIK: 0001440771 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 13, 2020
Total Value ($000): $96,131 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS | 321,500 | $30,645 | 31.9% | $64.91 | +5.1% | COM NEW | 53220K504 |
| — | IVERIC BIO INC | 2,362,240 | $13,323 | 13.9% | $1.52 | — | COM | 46583P102 |
| — | AMRYT PHARMA LTD - SPNR ADR | 765,236 | $9,458 | 9.8% | $12.36 | — | SPONSORED ADS | 03217L106 |
| — | CTI BIOPHARMA CORP | 3,768,597 | $8,102 | 8.4% | $2.16 | — | COM | 12648L601 |
| — | CATALYST BIOSCIENCES INC | 1,411,412 | $6,069 | 6.3% | $4.61 | — | COM NEW | 14888D208 |
| DMAC | DIAMEDICA THERAPEUTICS INC | 1,146,470 | $4,861 | 5.1% | $4.62 | +14.6% | COM NEW | 25253X207 |
| — | STRONGBRIDGE BIOPHARMA PLC | 1,924,956 | $4,042 | 4.2% | $2.10 | — | SHS USD | G85347105 |
| — | ANTARES PHARMA INC | 1,205,501 | $3,255 | 3.4% | $2.70 | — | COM | 036642106 |
| XOMA | XOMA CORP | 150,213 | $2,830 | 2.9% | $14.24 | +31.6% | COM NEW | 98419J206 |
| — | ADAMAS PHARMACEUTICALS INC | 657,467 | $2,709 | 2.8% | $4.81 | — | COM | 00548A106 |
| — | APOLLO ENDOSURGERY INC | 1,425,435 | $2,409 | 2.5% | $4.35 | — | COM | 03767D108 |
| — | NEOS THERAPEUTICS INC | 4,384,199 | $2,325 | 2.4% | $1.80 | — | COM | 64052L106 |
| CPIX | CUMBERLAND PHARMACEUTICALS | 589,497 | $1,892 | 2.0% | $5.80 | -43.3% | COM | 230770109 |
| — | CHIASMA INC | 350,000 | $1,505 | 1.6% | $4.30 | — | COM | 16706W102 |
| — | AFFIMED NV | 357,666 | $1,212 | 1.3% | $3.39 | — | COM | N01045108 |
| IDXG | INTERPACE BIOSCIENCES INC | 284,730 | $880 | 0.9% | $3.09 | — | COM | 46062X303 |
| — | PROGENITY INC | 68,062 | $614 | 0.6% | $9.00 | — | COM | 74319F107 |